Akso Health Group (AHG)

NASDAQ: AHG · IEX Real-Time Price · USD
1.09
0.00 (0.00%)
Jul 5, 2022 4:30 PM EDT - Market closed

Company Description

Akso Health Group operates a social e-commerce mobile platform in China. The company operates Xiaobai Maimai App, which offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment products, housewares, home appliances, etc.

It also offers consultancy and information technology support services; and trades in branded products, as well as promotes products. The company was formerly known as Xiaobai Maimai Inc. and changed its name to Akso Health Group in December 2021.

Akso Health Group was founded in 2014 and is headquartered in Beijing, China. As of July 13, 2021, Akso Health Group operates as a subsidiary of Webao Limited.

Akso Health Group
Country China
Founded 2013
Industry Credit Services
Sector Financial Services
Employees 113

Contact Details

Address:
Room 515, Floor 5, Jia No. 92-4 To 24
Beijing, Beijing 100020
China
Phone 86 10 5370 9902
Website ir.xiaobaimaimai.com

Stock Details

Ticker Symbol AHG
Exchange NASDAQ
Fiscal Year April - March
Reporting Currency US Dollars
CIK Code 1702318
ISIN Number US98422P1084
SIC Code 7389

Key Executives

Name Position
Yilin Wang Chief Executive Officer and Chairwomen of the Board
Rui Zhang Chief Financial Officer
Daisy Wang Investor Relation Contact
Ma Xiaoqin Corporate Secretary

Latest SEC Filings

Date Type Title
Jun 10, 2022 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Apr 15, 2022 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Dec 17, 2021 424B3 Prospectus [Rule 424(b)(3)]
Dec 15, 2021 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Dec 7, 2021 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Nov 19, 2021 144 Report of proposed sale of securities
Nov 3, 2021 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Oct 19, 2021 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Sep 21, 2021 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Sep 13, 2021 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]